1. In patients with chronic obstructive pulmonary disease, asthma, cystic fibrosis and aviation-related diseases, inhalable drug combinations containing glycerol or glycerol salts are used to treat or prevent tachycardia.
Inhalable Pharmaceutical composition containing glycopyrrolate or a Salt thereof； Pharmaceutical Combination； Device Management； use for the Treatment or prophylaxis of tachycardia in patients with chronic obstructive pulmonary disease, Asthma, Cystic Fibrosis and related diseases Adas in the Airways.La solicitud 201302542 describe al uso de una composición farmacéutica en forma de polvo seco inhalable que comprende entre 10 y 500 µg de bromuro de glicopirronio, monohidrato de lactosa y estearato de magnesio, la cual sirve para preparar un medicamento útil como un agente destinado a reducir el ritmo cardiaco.
